New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Lifecore Biomedical, Inc.
LFCR
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

192M

Drug Manufacturers - Specialty & Generic

5.21USD
Shape0.15 ( 2.96%)
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

-24%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

41%

Quote Panel

Shape
Updated October 20, 2024
1W 12.53 % 1M 6.54 % 3M -3.52 % 1Y -28.24 %

Key Metrics

Shape
  • Market Cap

    191.87M


  • Shares Outstanding

    36.83M


  • Share in Float

    32.55M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    5.21


  • Average Volume

    230214


  • Beta

    0.956


  • Range

    3.68-8.9


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.lifecore.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.49x

P/S Ratio

-40.82x

P/B Ratio

-32.5

Debt/Equity

5.1%

Net Margin

$0.1

EPS

How LFCR compares to sector?

P/E Ratio

Relative Strength

Shape

LFCR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$129M

Shape420%

2025-Revenue

$0.92

Shape-74%

2025-EPS

$401K

Shape105%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Craig-Hallum

initialise

Previous: Not converted

2024-09-05

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.42
vs 0.05

Q1.23

arrow
arrow

N/A

-0.24
vs -0.08

Q2.23

arrow
arrow

N/A

-0.22
vs -1.24

Q3.23

arrow
arrow

N/A

-0.89
vs NA

Q4.23

arrow
arrow

N/A

-0.32
vs -0.42

Q1.24

arrow
arrow

N/A

-0.24
vs -0.24

Q2.24

arrow
arrow

N/A

-0.41
vs -0.22

Q3.24

arrow
arrow

N/A

-0.15
vs -0.89

Q4.24

arrow
arrow

N/A

-0.27
vs -0.32

Q1.25

arrow
arrow

N/A

-0.19
vs -0.24

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-70%

38.8M  vs 129.5M

Q1.23

arrow
arrow

-48%

27.6M  vs 53.1M

Q2.23

arrow
arrow

-34%

31.5M  vs 47.6M

Q3.23

arrow
arrow

-43%

24.5M  vs 43.4M

Q4.23

arrow
arrow

-22%

30.1M  vs 38.8M

Q1.24

arrow
arrow

+29%

35.7M  vs 27.6M

Q2.24

arrow
arrow

+20%

37.9M  vs 31.5M

Q3.24

arrow
arrow

+1%

24.7M  vs 24.5M

Q4.24

arrow
arrow

+0%

30.2M  vs 30.1M

Q1.25

arrow
arrow

-3%

34.7M  vs 35.7M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-17%

-0.17
vs -0.14

Q1.23

arrow
arrow

-45%

-0.45
vs -0.17

Q2.23

arrow
arrow

+1961%

19.61
vs -0.45

Q3.23

arrow
arrow

-40%

-0.40
vs 19.61

Q4.23

arrow
arrow

+34%

0.34
vs -0.40

Q1.24

arrow
arrow

+26%

0.26
vs 0.34

Q2.24

arrow
arrow

-13%

-0.13
vs 0.26

Q3.24

arrow
arrow

+412%

4.12
vs -0.13

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News